OCT 09, 2019 07:53 PM PDT

Tailor-made Drug for Girl with Rare Genetic Disease

WRITTEN BY: Annie Lennon

Researchers have used personalized medicine to develop a tailor-made genetic treatment for a girl diagnosed with a rare genetic disease known as Batten disease. Called “milasen” after the girl, Mila Makovec, the research was funded by Mila’s Miracle Foundation, a charity set up by her family to cure devastating neurological diseases. 

Although Mila appeared healthy as a baby, as she grew older, her parents began to notice some worrying signs. At age 4, she began holding books closer to her face when looking at them and at 5, she began to lose her balance. Just before she turned 6, she was hospitalized for worsening symptoms including loss of vision, slurred speech and difficulty swallowing. A brain scan showed that her brain volume was shrinking and she began having seizures. 

Genetic testing eventually led to her diagnosis: Batten disease, a rare and fatal genetic disorder of the nervous system that manifests according to how the genes responsible have mutated. Appearing to affect lysosomes, which break down the cell’s waste products so they may be discarded or recycled, the disease eventually allows this waste material to build up, leading to cell death, including death of cells in the brain and eyes. 

Genetic analysis revealed that she had a unique mutation in a gene known as CLN7 (Kaiser: 2019). This particular mutation meant that her cells were unable to make the full protein needed for lysosomes. Recognizing this, the doctors realised that molecules known as antisense oligonucleotides may work for her case. Short and synthetic molecules, they are known to be able to bind to patient’s fault genetic codes and mask the error so proteins may be reproduced. 

Developing this knowledge into a treatment for Mila, known as “milasen”, so far the results have been positive. Before the treatment, Mila would experience an average of 15- 30 seizures per day, each lasting up to 2 minutes. Over the course of her treatment however, this frequency fell to between 0 and 20 seizures per day, each lasting less than one minute. Furthermore, Mila’s brain waves showed a decline of over 50% in the frequency and duration of seizures, with no harmful side effects having been observed. 

According to Mila’s mother, Julia Vitarello, “While we remain cautiously optimistic, we feel so fortunate that Mila was given a second chance (Rettner: 2019)." 

The researchers added that Mila’s case nevertheless clearly shows that antisense oligonucleotides "may deserve consideration as a platform for the rapid delivery of individualized treatments," although they also note that such a personalized approach is likely only to be considered for life-threatening conditions. 

 

Sources
 

Kaiser, Jocelyn: Science Mag 

Rachael: Live Science 

 

About the Author
  • Writer with a keen interest in genetics, psychology, health and everything in between. Currently focused on the interplay of genetics and society to understand how to create meaningful interactions and environments.
You May Also Like
OCT 17, 2019
Microbiology
OCT 17, 2019
Picturing a New Kind of Antibiotic
Scientists have deciphered the X-ray crystal structure of an enzyme that generates a unique broad spectrum antibiotic called obafluorin....
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Can Psychedelics Treat Alcoholism?
Some of the first research on psychedelics in clinical settings was to assess their efficacy in treating alcoholism. In fact, LSD-based treatments for the ...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Promising Drug Encourages Survival in Pancreatic Cancer
Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results ...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Diabetic Drugs Offer Protection Against Kidney Failure
Kidney failure is a consequence of diabetic kidney disease--roughly 3 million people are seeking treatment worldwide for kidney failure and the numbers are...
OCT 17, 2019
Cancer
OCT 17, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Diabetes: The next-generation therapy
A publication in Nature Communications describes a therapeutic that can avoid the side-effects of insulin in diabetic treatments particularly hypoglycemia....
Loading Comments...